long-term safety and efficacy of delayed-release dimethyl fumarate in paediatric patients with relapsing-remitting multiple sclerosis: a long-term extension of the focus study

R. Alroughani; P. Huppke; J. Pultz; B. Parks; V. Beynon

long-term safety and efficacy of delayed-release dimethyl fumarate in paediatric patients with relapsing-remitting multiple sclerosis: a long-term extension of the focus study

R. Alroughani
, P. Huppke
, J. Pultz
, B. Parks
, V. Beynon

Research output: Contribution to journal › Article › peer-review

Original language	American English
Pages (from-to)	147-148
Number of pages	2
Journal	Multiple Sclerosis Journal
Volume	25
State	Published - 2019
Externally published	Yes

Funding Agency

Kuwait Foundation for the Advancement of Sciences

Cite this

@article{71ec945b39974959927d88d9f18f1509,

title = "long-term safety and efficacy of delayed-release dimethyl fumarate in paediatric patients with relapsing-remitting multiple sclerosis: a long-term extension of the focus study",

author = "R. Alroughani and P. Huppke and J. Pultz and B. Parks and V. Beynon",

year = "2019",

language = "American English",

volume = "25",

pages = "147--148",

journal = "Multiple Sclerosis Journal",

issn = "1352-4585",

publisher = "SAGE Publications Ltd",

}

TY - JOUR

T1 - long-term safety and efficacy of delayed-release dimethyl fumarate in paediatric patients with relapsing-remitting multiple sclerosis: a long-term extension of the focus study

AU - Alroughani, R.

AU - Huppke, P.

AU - Pultz, J.

AU - Parks, B.

AU - Beynon, V.

PY - 2019

Y1 - 2019

M3 - Article

SN - 1352-4585

VL - 25

SP - 147

EP - 148

JO - Multiple Sclerosis Journal

JF - Multiple Sclerosis Journal

ER -